Novel three-dimensional bone ‘mapping’ software can help assess progression of osseous metastases from routine CT

by D. Thurtle, G. M. Treece, T. Barrett, V. J. Gnanapragasam
Published 2017-08-01

Integrating image guided-diagnostics, individualised prognostics and molecular profiling to identify targeted medicine strategies in men with aggressive primary non-metastatic pros...

by V.J. Gnanapragasam, A. George, A. Warren, T. Barrett, C. Massie, S. Pacey
Published 2020-07-01

The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

by V. J. Gnanapragasam, O. Bratt, K. Muir, L. S. Lee, H. H. Huang, P. Stattin, A. Lophatananon
Published 2018-02-01

Clinical utility and cost-modelling of the PHI test to triage referrals into image based diagnostic services for suspected prostate cancer: The PRIM (Phi to RefIne Mri) multi-centr...

by V.J. Gnanapragasam, L. Kim, N.E. Boxall, P. Archer, J. Aning, S. McCracken, T. Page, A. George
Published 2020-07-01

Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation

by M. G. Parry, T. E. Cowling, A. Sujenthiran, J. Nossiter, B. Berry, P. Cathcart, A. Aggarwal, H. Payne, J. van der Meulen, N. W. Clarke, V. J. Gnanapragasam
Published 2020-05-01

Trends and variations in risk stratified prostate cancer management: A cross-sectional study of the National Prostate Cancer Audit database using the Cambridge Prognostic Group cri...

by M.G. Parry, T.E. Cowling, A. Sujenthiran, J. Nossiter, B. Berry, P. Cathcart, A. Aggarwal, H. Payne, N.W. Clarke, J. Van Der Meulen, V.J. Gnanapragasam
Published 2020-07-01

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer

by K. M. Patel, K. E. van der Vos, C. G. Smith, F. Mouliere, D. Tsui, J. Morris, D. Chandrananda, F. Marass, D. van den Broek, D. E. Neal, V. J. Gnanapragasam, T. Forshew, B. W. van Rhijn, C. E. Massie, N. Rosenfeld, M. S. van der Heijden
Published 2017-07-01

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study

by H. Ross-Adams, A.D. Lamb, M.J. Dunning, S. Halim, J. Lindberg, C.M. Massie, L.A. Egevad, R. Russell, A. Ramos-Montoya, S.L. Vowler, N.L. Sharma, J. Kay, H. Whitaker, J. Clark, R. Hurst, V.J. Gnanapragasam, N.C. Shah, A.Y. Warren, C.S. Cooper, A.G. Lynch, R. Stark, I.G. Mills, H. Grönberg, D.E. Neal
Published 2015-09-01

Corrigendum to “Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study” [EBioMedicine 2 (9) (2015)...

by H. Ross-Adams, A.D. Lamb, M.J. Dunning, S. Halim, J. Lindberg, C.M. Massie, L.A. Egevad, R. Russell, A. Ramos-Montoya, S.L. Vowler, N.L. Sharma, J. Kay, H. Whitaker, J. Clark, R. Hurst, V.J. Gnanapragasam, N.C. Shah, A.Y. Warren, C.S. Cooper, A.G. Lynch, R. Stark, I.G. Mills, H. Grönberg, D.E. Neal
Published 2017-03-01